Annual revenue declined for four consecutive years, from KRW 20.72 billion in 2022 to KRW 15.63 billion in 2023, KRW 15.16 billion in 2024, and KRW 10.65 billion in 2025.
The operating loss moved from -KRW 3.75 billion in 2022 to -KRW 6.81 billion in 2023, then narrowed to -KRW 5.22 billion in 2024 and -KRW 4.48 billion in 2025, suggesting the loss width peaked in 2023 even as revenue kept shrinking.
On the net income line, the company posted a one-off net profit of KRW 89.59 billion in 2022 driven by non-operating factors, followed by large net losses of -KRW 182.83 billion in 2023 and -KRW 102.23 billion in 2024, before the loss narrowed sharply to -KRW 13.40 billion in 2025.
Quarterly data show the net loss spiked to -KRW 10.33 billion in Q4 2025, which appears linked to one-off factors such as impairment on the Saemangeum plant and bad-debt allowance on loans recognized around that period.
Revenue then came in at KRW 2.93 billion with an operating loss of -KRW 1.90 billion and a net loss of -KRW 1.06 billion in Q1 2026, before Q2 2026 revenue jumped to KRW 4.88 billion and net income turned positive at roughly KRW 970 million on a quarterly basis.
The operating loss nonetheless persisted at -KRW 1.33 billion in Q2 2026, indicating the net profit swing likely stemmed from non-operating items rather than a genuine improvement in core profitability.
Equity fell from KRW 117.32 billion in 2023 to KRW 53.12 billion in 2024 and recovered slightly to KRW 55.87 billion in 2025, reflecting both accumulated losses and capital restructuring such as the reverse stock split.
The debt ratio dropped from 34.3% in 2023 to 5.8% in 2025, an improvement that should be read alongside the shrinking equity base caused by cumulative losses.